PERCF (Percheron Therapeutics) Accounts Payable: $0.39 Mil (As of Dec. 2025)


What is Percheron Therapeutics Accounts Payable?

Percheron Therapeutics PERCF -0.18% Accounts Payable is $0.39 Mil as of Dec. 2025. The stock has 2 warning signs investors should review.

Percheron Therapeutics's Accounts Payable for the quarter that ended in Dec. 2025 was $0.39 Mil.

Percheron Therapeutics's quarterly Accounts Payable declined from Dec. 2024 ($1.45 Mil) to Jun. 2025 ($0.93 Mil) and declined from Jun. 2025 ($0.93 Mil) to Dec. 2025 ($0.39 Mil).

Percheron Therapeutics's annual Accounts Payable increased from Jun. 2023 ($0.69 Mil) to Jun. 2024 ($2.48 Mil) but then declined from Jun. 2024 ($2.48 Mil) to Jun. 2025 ($0.93 Mil).

Percheron Therapeutics Accounts Payable Related Terms

Percheron Therapeutics Accounts Payable Historical Data

* Premium members only.

The historical data trend for Percheron Therapeutics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Percheron Therapeutics Accounts Payable Chart

Percheron Therapeutics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.12 0.23 0.69 2.48 0.93

Percheron Therapeutics Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.20 2.48 1.45 0.93 0.39

Percheron Therapeutics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $0.39 Mil mean?
Percheron Therapeutics (PERCF) has a Accounts Payable of $0.39 Mil as of Dec. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Percheron Therapeutics and its competitors.
Is Percheron Therapeutics' Accounts Payable too high?
Percheron Therapeutics' current Accounts Payable is $0.39 Mil.
How does Percheron Therapeutics' Accounts Payable compare to ZTS and UTHR?
Percheron Therapeutics' Accounts Payable of $0.39 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Drug Manufacturers company?
A good Accounts Payable depends on the Drug Manufacturers industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Percheron Therapeutics and its competitors. Percheron Therapeutics's current Accounts Payable is $0.39 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Percheron Therapeutics stock overvalued right now?
Percheron Therapeutics (PERCF) has a current Accounts Payable of $0.39 Mil. The current Accounts Payable is $0.39 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Percheron Therapeutics (PERCF), the current Accounts Payable is $0.39 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Percheron Therapeutics Business Description

Other Exchanges AWY0:GermanyPER:Australia
Address 35 Collins Street, Level 30, Collins Place, Melbourne, VIC, AUS, 3000
Percheron Therapeutics Ltd is a biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The company operates into two operating segment: ATL1102 and ATL1103. Key revenue is generated from ATL1102.